BioLargo, Inc.
BLGO · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $52,346 | $62,428 | $83,302 | $57,242 |
| - Cash | $4,546 | $3,471 | $2,564 | $3,548 |
| + Debt | $1,494 | $3,668 | $3,053 | $2,554 |
| Enterprise Value | $49,294 | $62,625 | $83,791 | $56,248 |
| Revenue | $1,103 | $2,777 | $3,269 | $3,657 |
| % Growth | -60.3% | -15.1% | -10.6% | – |
| Gross Profit | $372 | $1,421 | $1,488 | $1,750 |
| % Margin | 33.7% | 51.2% | 45.5% | 47.9% |
| EBITDA | -$6,317 | -$1,721 | -$1,798 | -$1,538 |
| % Margin | -572.7% | -62% | -55% | -42.1% |
| Net Income | -$6,479 | -$1,192 | -$1,155 | -$1,014 |
| % Margin | -587.4% | -42.9% | -35.3% | -27.7% |
| EPS Diluted | -0.02 | -0.004 | -0.004 | -0.003 |
| % Growth | -412.8% | -2.6% | -11.8% | – |
| Operating Cash Flow | -$2,759 | -$2,118 | -$1,830 | -$1,916 |
| Capital Expenditures | $0 | $0 | $0 | $25 |
| Free Cash Flow | -$2,759 | -$2,118 | -$1,830 | -$1,891 |